Etizolam, an Anti-anxiety Agent, Attenuates Recurrence of Chronic Subdural Hematoma. Evaluation by Computed Tomography.

DOI 機関リポジトリ HANDLE Web Site PubMed 被引用文献2件 参考文献15件
  • HIRASHIMA Yutaka
    Department of Neurosurgery, Toyama Medical and Pharmaceutical University
  • KUWAYAMA Naoya
    Department of Neurosurgery, Toyama Medical and Pharmaceutical University
  • HAMADA Hideo
    Department of Neurosurgery, Toyama Medical and Pharmaceutical University
  • HAYASHI Nakamasa
    Department of Neurosurgery, Toyama Medical and Pharmaceutical University
  • ENDO Shunro
    Department of Neurosurgery, Toyama Medical and Pharmaceutical University

書誌事項

タイトル別名
  • —Evaluation by Computed Tomography—

この論文をさがす

抄録

Etizolam, an anti-anxiety agent which is an antagonist of platelet-activating factor receptors, was administered to patients with chronic subdural hematoma (CSH) after hematoma removal to assess the effectiveness for preventing recurrence compared with control patients not given the drug after surgery. The remaining volumes of subdural hematomas on brain computed tomography were measured approximately 1 month after removal. Volume in the etizolam group (15 patients) was significantly smaller than in the control group (24 patients). Hematoma recurrence was not detected in the etizolam group 3 months after surgery, but occurred in the control group. The difference was significant. Etizolam administration may be useful for the prevention of recurrence of CSH.<br>

収録刊行物

被引用文献 (2)*注記

もっと見る

参考文献 (15)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ